Informationen:
Fehler:
ID
34777
Beschreibung
Nutritional Intervention With Moderately High-protein, Low-glycemic Load Products in Type-2 Diabetes Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01264523
Link
https://clinicaltrials.gov/show/NCT01264523
Stichworte
Versionen (1)
- 28.01.19 28.01.19 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
28. Januar 2019
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Type-2 Diabetes NCT01264523
Eligibility Type-2 Diabetes NCT01264523
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Type-2 Diabetes NCT01264523
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Diabetes Mellitus, Non-Insulin-Dependent
Item
clinically diagnosed of type-2 diabetes
boolean
C0011860 (UMLS CUI [1])
Diet therapy | Metformin
Item
under dietary treatment or with metformin
boolean
C0012159 (UMLS CUI [1])
C0025598 (UMLS CUI [2])
C0025598 (UMLS CUI [2])
Body mass index
Item
body mass index (bmi) between 22 and 35 kg/m2
boolean
C1305855 (UMLS CUI [1])
Body mass index
Item
bmi under 22 or over 35 kg/m2
boolean
C1305855 (UMLS CUI [1])
Pharmacotherapy | Exception Metformin
Item
to follow a pharmacological treatment with other drugs but metformin
boolean
C0013216 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0025598 (UMLS CUI [2,2])
C1705847 (UMLS CUI [2,1])
C0025598 (UMLS CUI [2,2])
Dependence on Insulin
Item
to be already insulin-dependent
boolean
C0439857 (UMLS CUI [1,1])
C0021641 (UMLS CUI [1,2])
C0021641 (UMLS CUI [1,2])
Weight-Loss Agents | Hormone replacement therapy | Thyroid function altered
Item
to have other concomitant pharmacological treatments for weight loss, hormonal substitutive therapy, altered thyroid function, etc. without an stable dosage (at least three months prior the beginning of the study).
boolean
C0376606 (UMLS CUI [1])
C0282402 (UMLS CUI [2])
C2242456 (UMLS CUI [3,1])
C0392747 (UMLS CUI [3,2])
C0282402 (UMLS CUI [2])
C2242456 (UMLS CUI [3,1])
C0392747 (UMLS CUI [3,2])
Complications Due to Non-Insulin-Dependent Diabetes Mellitus | Microangiopathy | Polyneuropathy | Heart Disease | Hepatic impairment | Renal Insufficiency
Item
to suffer from complications due to type 2 diabetes (microangiopathy, polyneuropathy, cardiopathy, hepatic and renal impairments, etc)
boolean
C0009566 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C0011860 (UMLS CUI [1,3])
C0155765 (UMLS CUI [2])
C0152025 (UMLS CUI [3])
C0018799 (UMLS CUI [4])
C0948807 (UMLS CUI [5])
C1565489 (UMLS CUI [6])
C0678226 (UMLS CUI [1,2])
C0011860 (UMLS CUI [1,3])
C0155765 (UMLS CUI [2])
C0152025 (UMLS CUI [3])
C0018799 (UMLS CUI [4])
C0948807 (UMLS CUI [5])
C1565489 (UMLS CUI [6])
Hypercholesterolemia Uncontrolled | Hypertriglyceridemia Uncontrolled
Item
to have a recent (less than 3 months before the beginning of the study) uncontrolled diagnostic of hypercholesterolemia and/or hypertriglyceridemia.
boolean
C0020443 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0020557 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0205318 (UMLS CUI [1,2])
C0020557 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])